HSPG2 抗体
Our Local Distributor
北京 101111
Quick Overview for HSPG2 抗体 (ABIN7881008)
抗原
See all HSPG2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Anti-Perlecan Antibody (HSPG)
-
纯化方法
- Protein G affinity chromatography
-
免疫原
- A murine EHS laminin preparation was used as the immunogen for the anti-Perlecan antibody.
-
亚型
- IgG2a, kappa
-
-
-
-
应用备注
-
Optimal dilution of the anti-Perlecan antibody should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in pH 9 10 mM Tris with 1 mM EDTA for 10-20 min followed by cooling at RT for 20 min
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Prediluted in 1X PBS, 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide, *For IHC use only*
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store the anti-Perlecan antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- HSPG2 (Heparan Sulfate Proteoglycan 2 (HSPG2))
-
别名
- Perlecan
-
背景
- This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment.
-
UniProt
- P98160
-
途径
- Glycosaminoglycan Metabolic Process, Lipid Metabolism
抗原
-